<DOC>
	<DOCNO>NCT00928681</DOCNO>
	<brief_summary>study investigate safety efficacy property PF-00547659 patient active ulcerative colitis</brief_summary>
	<brief_title>A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>A positive histological diagnosis UC ≥3 month prior entry study . If histological diagnosis available sign symptom suggest UC , subject 's eligibility discuss Pfizer . Active UC define score ≥6 Mayo score . An endoscopic ( flexible sigmoidoscopy ) subscore ≥2 Mayo score determine within 7 day first dose . Subjects UC , confine proctitis flexible sigmoidoscopy . Subjects surgery treatment UC likely require surgery within duration study . Subjects display clinical sign ischemic colitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>